Difference between revisions of "Ultrasound CEUS BC"
Jump to navigation
Jump to search
Line 19: | Line 19: | ||
'''Approved Call Summaries:''' | '''Approved Call Summaries:''' | ||
+ | *[[Media:12 10 2021 QIBA CEUS BC Call Summary-FINAL.pdf|December 10, 2021]] | ||
*[[Media:11 12 2021 QIBA CEUS BC Call Summary-FINAL.pdf|November 12, 2021]] | *[[Media:11 12 2021 QIBA CEUS BC Call Summary-FINAL.pdf|November 12, 2021]] | ||
*[[Media:10 08 2021 QIBA CEUS BC Call Summary-FINAL-3.pdf|October 8, 2021]] | *[[Media:10 08 2021 QIBA CEUS BC Call Summary-FINAL-3.pdf|October 8, 2021]] |
Revision as of 21:53, 7 December 2021
- Co-chairs: Michalakis (Mike) A. Averkiou, PhD; Richard G. Barr, MD, PhD; Todd Erpelding, PhD, MSE
- RSNA Staff Support: Julie Lisiecki
Project Snapshot
The Contrast Enhanced Ultrasound Biomarker Committee (CEUS BC) seeks to develop a quantitative imaging profile for CEUS imaging.
Project Descriptions:
CEUS Biomarker Committee Proposal:
Recent Meetings
Approved Call Summaries:
- December 10, 2021
- November 12, 2021
- October 8, 2021
- September 10, 2021
- August 13, 2021
- June 11, 2021
- May 14, 2021
- April 09, 2021
- March 12, 2021
- February 12, 2021
CEUS Task Force (TF) Call Summaries
Working Documents
Statistical Reference Documents
Workflow Documents
Historical Background - Formation of the Group
Reference Materials
Original Proposal to the QIBA Steering Committee:
Vendor Press Release:
Presentations: